389650 — NextBioMedical Co Balance Sheet
0.000.00%
- KR₩334bn
- KR₩304bn
- KR₩10bn
Annual balance sheet for NextBioMedical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 14,797 | 14,290 | 41,609 |
Net Total Accounts Receivable | |||
Net Total Receivables | 505 | 1,216 | 2,244 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 17,521 | 17,968 | 46,888 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 11,735 | 11,428 | 11,270 |
Net Intangible Assets | |||
Long Term Investments | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 32,136 | 29,643 | 58,844 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 30,968 | 33,786 | 11,884 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Minority Interest | |||
Total Other Liabilities | |||
Total Funded Status | |||
Total Liabilities | 32,390 | 35,544 | 13,653 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | -254 | -5,901 | 45,191 |
Total Liabilities & Shareholders' Equity | 32,136 | 29,643 | 58,844 |
Total Common Shares Outstanding |